Company page

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a public company traded under the ticker HALO in the American market. With a market capitalization of approximately $8.24 billion, Halozyme focuses on developing innovative therapies to improve patient outcomes. The company is known for its proprietary enzyme technology, which enhances the delivery of biologic drugs.